Francis J. T. Fildes
Direttore/Membro del Consiglio presso ProSkelia SAS
Profilo
Francis J.
T.
Fildes is currently a Director at ProSkelia SAS.
He previously served as an Independent Director at Flamel Technologies SA, Director at Keryx Biopharmaceuticals, Inc., Director at Piramed Ltd., Non-Executive Director at Kyowa Kirin International Plc, and Director at Kyowa Kirin Ltd.
He was also the Managing Director at Fildes Partners Ltd.
from 2002 to 2014.
Prior to that, he was the Senior Vice President & Head-Global Development at AstraZeneca PLC from 1999 to 2002.
Fildes obtained his undergraduate degree from The University of Liverpool.
Posizioni attive di Francis J. T. Fildes
Società | Posizione | Inizio |
---|---|---|
ProSkelia SAS
ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Francis J. T. Fildes
Società | Posizione | Fine |
---|---|---|
AVADEL PHARMACEUTICALS PLC | Direttore/Membro del Consiglio | 02/05/2018 |
Fildes Partners Ltd. | Amministratore Delegato | - |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/12/2002 |
KERYX BIOPHARMACEUTICALS | Direttore/Membro del Consiglio | - |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Direttore/Membro del Consiglio | - |
Formazione di Francis J. T. Fildes
The University of Liverpool | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
Aziende private | 7 |
---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Commercial Services |
ProSkelia SAS
ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Commercial Services |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Health Technology |
Fildes Partners Ltd. |
- Borsa valori
- Insiders
- Francis J. T. Fildes